It's All Off: $160bn PfizerGan Deal Collapses On Latest US Treasury Edicts
This article was originally published in Scrip
Pfizer Inc. and Allergan PLC have terminated "by mutual agreement" their $160bn merger . The decision was driven by new US Treasury Department rules endorsed by President Barack Obama to prevent tax inversion deals that were announced on April 4, 2016.
Register for our free email digests: